Skip to main content

Peer Review reports

From: Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reports

Original Submission
2 Sep 2020 Submitted Original manuscript
2 Jan 2021 Reviewed Reviewer Report - Tugrul Elverdi
23 Jan 2021 Reviewed Reviewer Report - Ahmet Emre Eşkazan
22 Feb 2021 Author responded Author comments - Junichiro Yuda
Resubmission - Version 2
22 Feb 2021 Submitted Manuscript version 2
24 Feb 2021 Reviewed Reviewer Report - Ahmet Emre Eşkazan
26 Feb 2021 Reviewed Reviewer Report - Tugrul Elverdi
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
3 Mar 2021 Editorially accepted
25 Mar 2021 Article published 10.1186/s13256-021-02771-z

You can find further information about peer review here.

Back to article page